Biosimilars Market size was valued at USD 25.10 Billion in 2022 and is expected to reach USD 91.81 Billion By 2030 and grow at a CAGR of 17.6% over the forecast period of 2023-2030. This impressive surge is driven by a confluence of factors, including: Significant cost savings: Biosimilars, highly similar versions of existing biologic drugs, offer substantial cost...